Answers are grounded in this paper and cite their sources.
Despite the well‐known association of Epstein–Barr virus (EBV), a lymphocryptovirus (LCV), with multiple sclerosis, a clear pathogenic role for disease progression has not been established. The translationally relevant experimental autoimmune encephalomyelitis (EAE) model in marmoset monkeys revealed that LCV‐infected B cells have a central pathogenic role in the activation of T cells that drive EAE progression. We hypothesized that LCV‐infected B cells induce T‐cell functions relevant for EAE progression. In the current study, we examined the ex vivo cross‐talk between lymph node mononuclear cells (MNCs) from EAE marmosets and (semi‐) autologous EBV‐infected B‐lymphoblastoid cell lines (B‐LCLs). Results presented here demonstrate that infection with EBV B95‐8 has a strong impact on gene expression profile of marmoset B cells, particularly those involved with antigen processing and presentation or co‐stimulation to T cells. At the cellular level, we observed that MNC co‐culture with B‐LCLs induced decrease of CCR7 expression on T cells from EAE responder marmosets, but not in EAE monkeys without clinically evident disease. B‐LCL interaction with T cells also resulted in significant loss of CD27 expression and reduced expression of IL‐23R and CCR6, which coincided with enhanced IL‐17A production. These results highlight the profound impact that EBV‐infected B‐LCL cells can have on second and third co‐stimulatory signals involved in (autoreactive) T‐cell activation.
No takes yet. Share an insight, caveat, or question.
Dunham et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: